Efficacy and Safety of Exenatide versus Insulin in Type 2 Diabetes Mellitus: Systematic Review and Meta-Analysis
作者: unknown
刊名: International Journal of Management, Economics and Social Sciences, 2019, Vol.8 (3)
来源数据库: IJMESS Int’l Publishers
原始语种摘要: Exenatide is one of a new class of medications (incretin mimetics) for the treatment of type 2 diabetes mellitus and was approved in April 2005 by the U.S. Food and Drug Administration. We undertook a systematic review and meta-analysis of exenatide therapy compared to both placebo and insulin therapy in terms of main efficacy parameters and safety. We searched PubMed for randomized controlled clinical studies of type 2 diabetes mellitus of at least 12 weeks' duration published from June 2003 to July 2010.
全文获取路径: IJMESS国际出版社 

  • incretin 肠降血糖素
  • diabetes 糖尿病
  • versus 
  • insulin 胰岛素
  • controlled 受控
  • systematic 有系统的
  • published 公布的
  • approved 认可的
  • efficacy 效验
  • duration 持续时间